Can the interplay between androgen signaling and PSMA expression be leveraged for theranostic applications?

被引：8

作者：

Batra, Jaspreet S. ^{[1
]}

Pienta, Kenneth J. ^{[2
,3
]}

Pomper, Martin G. ^{[1
,2
,3
]}

Gorin, Michael A. ^{[1
,2
,3
]}

Rowe, Steven P. ^{[1
,2
,3
]}

机构：

[1] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, 601 N Caroline St,Room 3233, Baltimore, MD 21287 USA

[2] Johns Hopkins Univ, Sch Med, James Buchanan Brady Urol Inst, Baltimore, MD USA

[3] Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD 21205 USA

来源：

TRANSLATIONAL ANDROLOGY AND UROLOGY | 2019年 / 8卷

关键词：

D O I：

10.21037/tau.2019.03.13

中图分类号：

R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

摘要：

[No abstract available]

引用

页码：S263 / S264

页数：2

共 9 条

[1]

Bostwick DG, 1998, CANCER-AM CANCER SOC, V82, P2256, DOI 10.1002/(SICI)1097-0142(19980601)82:11<2256::AID-CNCR22>3.0.CO

[2]

2-S

[3] Metastatic prostate cancer remains incurable, why? [J].

Dong, Liang ;

Zieren, Richard C. ;

Xue, Wei ;

de Reijke, Theo M. ;

Pienta, Kenneth J. .

ASIAN JOURNAL OF UROLOGY, 2019, 6 (01) :26-41

[4] Noninvasive measurement of androgen receptor signaling with a positron-emitting radiopharmaceutical that targets prostate-specific membrane antigen [J].

Evans, Michael J. ;

Smith-Jones, Peter M. ;

Wongvipat, John ;

Navarro, Vincent ;

Kim, Sae ;

Bander, Neil H. ;

Larson, Steven M. ;

Sawyers, Charles L. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (23) :9578-9582

[5] [177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study [J].

Hofman, Michael S. ;

Violet, John ;

Hicks, Rodney J. ;

Ferdinandus, Justin ;

Thang, Sue Ping ;

Akhurst, Tim ;

Iravani, Amir ;

Kong, Grace ;

Kumar, Aravind Ravi ;

Murphy, Declan G. ;

Eu, Peter ;

Jackson, Price ;

Scalzo, Mark ;

Williams, Scott G. ;

Sandhu, Shahneen .

LANCET ONCOLOGY, 2018, 19 (06) :825-833

[6] 68Ga-PSMA-11 PET Imaging of Response to Androgen Receptor Inhibition: First Human Experience [J].

Hope, Thomas A. ;

Truillet, Charles ;

Ehman, Eric C. ;

Afshar-Oromieh, Ali ;

Aggarwal, Rahul ;

Ryan, Charles J. ;

Carroll, Peter R. ;

Small, Eric J. ;

Evans, Michael J. .

JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (01) :81-84

[7] Theranostics of prostate cancer: from molecular imaging to precision molecular radiotherapy targeting the prostate specific membrane antigen [J].

Kulkarni, Harshad R. ;

Singh, Aviral ;

Langbein, Thomas ;

Schuchardt, Christiane ;

Mueller, Dirk ;

Zhang, Jingjing ;

Lehmann, Coline ;

Baum, Richard P. .

BRITISH JOURNAL OF RADIOLOGY, 2018, 91 (1091)

[8] Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancer [J].

Luckerath, Katharina ;

Wei, Liu ;

Fendler, Wolfgang P. ;

Evans-Axelsson, Susan ;

Stuparu, Andreea D. ;

Slavik, Roger ;

Mona, Christine E. ;

Calais, Jeremie ;

Rettig, Matthew ;

Reiter, Robert E. ;

Herrmann, Ken ;

Radu, Caius G. ;

Czernin, Johannes ;

Eiber, Matthias .

EJNMMI RESEARCH, 2018, 8

[9] Flare on Serial Prostate-Specific Membrane Antigen-Targeted 18F-DCFPyL PET/CT Examinations in Castration-Resistant Prostate Cancer: First Observations [J].

Zukotynski, Katherine A. ;

Valliant, John ;

Benard, Francois ;

Rowe, Steven P. ;

Kim, Chun K. ;

Pomper, Martin G. ;

Cho, Steve Y. .

CLINICAL NUCLEAR MEDICINE, 2018, 43 (03) :213-216

← 1 →